Westermann F - Search Results

1

A mechanistic classification of clinical phenotypes in neuroblastoma.

Ackermann S, Cartolano M, Hero B, Welte A, Kahlert Y, Roderwieser A, Bartenhagen C, Walter E, Gecht J, Kerschke L, Volland R, Menon R, Heuckmann JM, Gartlgruber M, Hartlieb S, Henrich KO, Okonechnikov K, Altmüller J, Nürnberg P, Lefever S, de Wilde B, Sand F, Ikram F, Rosswog C, Fischer J, Theissen J, Hertwig F, Singhi AD, Simon T, Vogel W, Perner S, Krug B, Schmidt M, Rahmann S, Achter V, Lang U, Vokuhl C, Ortmann M, Büttner R, Eggert A, Speleman F, O'Sullivan RJ, Thomas RK, Berthold F, Vandesompele J, Schramm A, Westermann F, Schulte JH, Peifer M, Fischer M. Ackermann S, et al. Among authors: westermann f. Science. 2018 Dec 7;362(6419):1165-1170. doi: 10.1126/science.aat6768. Science. 2018. PMID: 30523111 Free PMC article.

2

Effective methods for bulk RNA-seq deconvolution using scnRNA-seq transcriptomes.

Cobos FA, Panah MJN, Epps J, Long X, Man TK, Chiu HS, Chomsky E, Kiner E, Krueger MJ, di Bernardo D, Voloch L, Molenaar J, van Hooff SR, Westermann F, Jansky S, Redell ML, Mestdagh P, Sumazin P. Cobos FA, et al. Among authors: westermann f. Genome Biol. 2023 Aug 1;24(1):177. doi: 10.1186/s13059-023-03016-6. Genome Biol. 2023. PMID: 37528411 Free PMC article.

3

Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks.

Khan J, Wei JS, Ringnér M, Saal LH, Ladanyi M, Westermann F, Berthold F, Schwab M, Antonescu CR, Peterson C, Meltzer PS. Khan J, et al. Among authors: westermann f. Nat Med. 2001 Jun;7(6):673-9. doi: 10.1038/89044. Nat Med. 2001. PMID: 11385503 Free PMC article.

4

Fluorescence in situ hybridization analyses of chromosome band 1p36 in neuroblastoma detect two classes of alterations.

Spitz R, Hero B, Westermann F, Ernestus K, Schwab M, Berthold F. Spitz R, et al. Among authors: westermann f. Genes Chromosomes Cancer. 2002 Jul;34(3):299-305. doi: 10.1002/gcc.10070. Genes Chromosomes Cancer. 2002. PMID: 12007190

5

Neuroblastoma: biology and molecular and chromosomal pathology.

Schwab M, Westermann F, Hero B, Berthold F. Schwab M, et al. Among authors: westermann f. Lancet Oncol. 2003 Aug;4(8):472-80. doi: 10.1016/s1470-2045(03)01166-5. Lancet Oncol. 2003. PMID: 12901961 Review.

6

cDNA array-CGH profiling identifies genomic alterations specific to stage and MYCN-amplification in neuroblastoma.

Chen QR, Bilke S, Wei JS, Whiteford CC, Cenacchi N, Krasnoselsky AL, Greer BT, Son CG, Westermann F, Berthold F, Schwab M, Catchpoole D, Khan J. Chen QR, et al. Among authors: westermann f. BMC Genomics. 2004 Sep 20;5:70. doi: 10.1186/1471-2164-5-70. BMC Genomics. 2004. PMID: 15380028 Free PMC article.

7

Prediction of clinical outcome using gene expression profiling and artificial neural networks for patients with neuroblastoma.

Wei JS, Greer BT, Westermann F, Steinberg SM, Son CG, Chen QR, Whiteford CC, Bilke S, Krasnoselsky AL, Cenacchi N, Catchpoole D, Berthold F, Schwab M, Khan J. Wei JS, et al. Among authors: westermann f. Cancer Res. 2004 Oct 1;64(19):6883-91. doi: 10.1158/0008-5472.CAN-04-0695. Cancer Res. 2004. PMID: 15466177 Free PMC article.

8

Characterization of a complex genomic alteration on chromosome 2p that leads to four alternatively spliced fusion transcripts in the neuroblastoma cell lines IMR-5, IMR-5/75 and IMR-32.

Oberthuer A, Skowron M, Spitz R, Kahlert Y, Westermann F, Mehler K, Berthold F, Fischer M. Oberthuer A, et al. Among authors: westermann f. Gene. 2005 Dec 19;363:41-50. doi: 10.1016/j.gene.2005.07.038. Epub 2005 Oct 10. Gene. 2005. PMID: 16216448

9

Reduced expression of CAMTA1 correlates with adverse outcome in neuroblastoma patients.

Henrich KO, Fischer M, Mertens D, Benner A, Wiedemeyer R, Brors B, Oberthuer A, Berthold F, Wei JS, Khan J, Schwab M, Westermann F. Henrich KO, et al. Among authors: westermann f. Clin Cancer Res. 2006 Jan 1;12(1):131-8. doi: 10.1158/1078-0432.CCR-05-1431. Clin Cancer Res. 2006. PMID: 16397034

10

Customized oligonucleotide microarray gene expression-based classification of neuroblastoma patients outperforms current clinical risk stratification.

Oberthuer A, Berthold F, Warnat P, Hero B, Kahlert Y, Spitz R, Ernestus K, König R, Haas S, Eils R, Schwab M, Brors B, Westermann F, Fischer M. Oberthuer A, et al. Among authors: westermann f. J Clin Oncol. 2006 Nov 1;24(31):5070-8. doi: 10.1200/JCO.2006.06.1879. J Clin Oncol. 2006. PMID: 17075126

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

147 results

Search Page